The regulatory agencies of six European countries are now actively prompting clinical trials sponsors to publicly report their clinical trial results—and have the power to issue fines of up to €250,000 ($243,000) for noncompliance.
EMA pilot to provide regulatory support to selected ATMP developers
from BioPharma-Reporter.com
AstraZeneca’s Alexion acquires genomic medicine company
from BioPharma-Reporter.com
Kite receives FDA approval for commercial production at California viral vector facility
from BioPharma-Reporter.com
Samsung Bio looks to streamline antibody development process and help industry idenfity molecules with IND potential
from BioPharma-Reporter.com
Q&A: Precision for Medicine VP on the present & future of personalized medicine
Clinical evolution
Epic launches program to ‘unify’ clinical research with care delivery
Patient centricity
Science 37 taps NuvoAir to enable remote collection of lung health endpoints
Patient centricity
Intranasal TIPs therapy study shows potential to reduce COVID-19 transmission
COVID-19
